申请人:Merck & Co. Inc.
公开号:US06369076B1
公开(公告)日:2002-04-09
Novel 5-benzyl-octahydroindoles and 6-benzyl-decahydroquinolines substituted in the 1-position are effective as NMDA NR2B antagonists useful for relieving pain.
小说中1-位置取代的5-苄基-辛氢吲哚和6-苄基-癸氢喹啉作为NMDA NR2B拮抗剂,可有效缓解疼痛。